NM_144773.4:c.629A>G
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 3P and 1B. PP3_ModeratePP5BS2_Supporting
The NM_144773.4(PROKR2):c.629A>G(p.Gln210Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000743 in 1,614,138 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_144773.4 missense
Scores
Clinical Significance
Conservation
Publications
- hypogonadotropic hypogonadism 3 with or without anosmiaInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
- hypogonadotropic hypogonadismInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Kallmann syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- septooptic dysplasiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PROKR2 | ENST00000678254.1 | c.629A>G | p.Gln210Arg | missense_variant | Exon 3 of 3 | NM_144773.4 | ENSP00000504128.1 | |||
| PROKR2 | ENST00000217270.4 | c.629A>G | p.Gln210Arg | missense_variant | Exon 3 of 3 | 1 | ENSP00000217270.3 | |||
| PROKR2 | ENST00000678059.1 | c.521A>G | p.Gln174Arg | missense_variant | Exon 3 of 3 | ENSP00000503366.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152248Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000795 AC: 2AN: 251480 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461890Hom.: 0 Cov.: 32 AF XY: 0.00000688 AC XY: 5AN XY: 727246 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152248Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74382 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Hypogonadotropic hypogonadism 3 with or without anosmia Pathogenic:2
- -
- -
not specified Uncertain:1
Variant summary: PROKR2 c.629A>G (p.Gln210Arg) results in a conservative amino acid change located in the GPCR, rhodopsin-like, 7TM domain (IPR017452) of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 251480 control chromosomes. c.629A>G has been reported in the literature as segregating in a semi-dominant mode of transmission with isolated anosmia when inherited alone and anosmia with hypogonadism when inherited as a compound heterozygote with another PROKR2 variant, c.518T>G (p.Leu173Arg) in individuals from one family that have been subsequently cited by others (example, Dode_2006, Sarfati_2013). These data indicate that the variant may be associated with disease. At least two publications report conflicting experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in complete loss of PROK2 binding activity (example, Sbai_2014) while another recent study showed conflicting results with a prediction of a homozygous genotype being likely pathogenic and a heterozygous genotype being likely benign (Cox_2018). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at